ID

29646

Descrizione

Study ID: 104385 Clinical Study ID: RES104385 Study Title: A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00318630 https://clinicaltrials.gov/ct2/show/NCT00318630 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Rosiglitazone XR,Avandia XR,Avandia Study Indication: Asthma This ODM-file contains Treatment Timetable. Time: Treatment Period 2.

collegamento

https://clinicaltrials.gov/ct2/show/NCT00318630

Keywords

versioni (1)

1. 10/04/18 10/04/18 - Sarah Riepenhausen

Titolare del copyright

GlaxoSmithKline

Caricato su

10 aprile 2018

DOI

Per favore, per richiedere un accesso.

Licenza